CN108026029B - 经选择的γ-羟基丁酸的酰胺及其在治疗酒精误用中的用途 - Google Patents

经选择的γ-羟基丁酸的酰胺及其在治疗酒精误用中的用途 Download PDF

Info

Publication number
CN108026029B
CN108026029B CN201680045364.9A CN201680045364A CN108026029B CN 108026029 B CN108026029 B CN 108026029B CN 201680045364 A CN201680045364 A CN 201680045364A CN 108026029 B CN108026029 B CN 108026029B
Authority
CN
China
Prior art keywords
formula
alcohol
compound
treatment
acget61
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201680045364.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN108026029A (zh
Inventor
罗伯特·卡恰利亚
安东内拉·洛克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Farmaceutico CT SRL
Original Assignee
Laboratorio Farmaceutico CT SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Farmaceutico CT SRL filed Critical Laboratorio Farmaceutico CT SRL
Publication of CN108026029A publication Critical patent/CN108026029A/zh
Application granted granted Critical
Publication of CN108026029B publication Critical patent/CN108026029B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201680045364.9A 2015-08-04 2016-08-03 经选择的γ-羟基丁酸的酰胺及其在治疗酒精误用中的用途 Expired - Fee Related CN108026029B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITUB2015A002860A ITUB20152860A1 (it) 2015-08-04 2015-08-04 Selezionata amide dell?acido ?-idrossibutirrico e suoi usi nel trattamento dell?abuso da alcool
IT102015000041820 2015-08-04
PCT/EP2016/068517 WO2017021438A1 (en) 2015-08-04 2016-08-03 SELECTED AMIDE OF γ -HYDROXYBUTYRIC ACID AND USES THEREOF IN THE TREATMENT OF ALCOHOL MISUSE

Publications (2)

Publication Number Publication Date
CN108026029A CN108026029A (zh) 2018-05-11
CN108026029B true CN108026029B (zh) 2020-12-04

Family

ID=54542363

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680045364.9A Expired - Fee Related CN108026029B (zh) 2015-08-04 2016-08-03 经选择的γ-羟基丁酸的酰胺及其在治疗酒精误用中的用途

Country Status (24)

Country Link
US (1) US10336687B2 (enExample)
EP (1) EP3331853B1 (enExample)
JP (1) JP6832336B2 (enExample)
KR (1) KR102817897B1 (enExample)
CN (1) CN108026029B (enExample)
AU (1) AU2016302869B2 (enExample)
CA (1) CA2994599C (enExample)
CL (1) CL2018000282A1 (enExample)
CO (1) CO2018002428A2 (enExample)
DK (1) DK3331853T3 (enExample)
EA (1) EA033769B9 (enExample)
ES (1) ES2776628T3 (enExample)
GE (1) GEP20207107B (enExample)
IL (1) IL257314B (enExample)
IT (1) ITUB20152860A1 (enExample)
MX (1) MX2018001239A (enExample)
MY (1) MY185942A (enExample)
PH (1) PH12018550008A1 (enExample)
PL (1) PL3331853T3 (enExample)
PT (1) PT3331853T (enExample)
SM (1) SMT202000337T1 (enExample)
UA (1) UA121994C2 (enExample)
WO (1) WO2017021438A1 (enExample)
ZA (1) ZA201801402B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200035035A (ko) 2017-07-31 2020-04-01 노파르티스 아게 코카인 사용 감소 또는 코카인 사용 재발 예방에 있어서 마보글루란트의 용도
AU2018310882C1 (en) * 2017-07-31 2021-12-09 Novartis Ag Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol use
CN113185403A (zh) * 2021-07-02 2021-07-30 山东国邦药业有限公司 一种甲醚制备环丙胺中间体环丙甲酸甲酯的方法
WO2023126076A1 (en) * 2022-01-03 2023-07-06 Laboratorio Farmaceutico C.T. S.R.L. Medical use of an amide of y-hydroxybutyric acid in the treatment of fragile x syndrome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283782B1 (it) * 1996-08-09 1998-04-30 Ct Lab Farm Srl Uso di ammidi dell'acido gamma-idrossibutirrico nel trattamento di tossicodipendenze,ed in particolare sell'alcolismo

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
The New Compound GET73, N-[(4-trifluoromethyl)benzyl]4-metho-xybutyramide, Regulates Hippocampal Aminoacidergic Transmission Possibly Via an Allosteric Modulation of mGlu5 Receptor. Behavioural Evidence of its "Anti-Alcohol" and Anxiolytic Properties;L. Ferraro 等;《Current Medicinal Chemistry》;20131231;第20卷(第1期);第3339-3357页 *

Also Published As

Publication number Publication date
EA033769B1 (ru) 2019-11-22
ES2776628T3 (es) 2020-07-31
PH12018550008A1 (en) 2018-07-09
EA201890419A1 (ru) 2018-07-31
JP2018523644A (ja) 2018-08-23
AU2016302869B2 (en) 2020-10-22
EA033769B9 (ru) 2020-04-10
MX2018001239A (es) 2018-07-06
UA121994C2 (uk) 2020-08-25
CL2018000282A1 (es) 2018-07-13
WO2017021438A1 (en) 2017-02-09
EP3331853A1 (en) 2018-06-13
ZA201801402B (en) 2019-01-30
KR102817897B1 (ko) 2025-06-05
GEAP202014717A (en) 2020-01-27
CO2018002428A2 (es) 2018-07-10
SMT202000337T1 (it) 2020-07-08
CA2994599A1 (en) 2017-02-09
US20180230086A1 (en) 2018-08-16
CN108026029A (zh) 2018-05-11
PT3331853T (pt) 2020-02-25
KR20180066033A (ko) 2018-06-18
IL257314A (en) 2018-03-29
DK3331853T3 (da) 2020-03-16
JP6832336B2 (ja) 2021-02-24
IL257314B (en) 2020-04-30
CA2994599C (en) 2023-08-29
PL3331853T3 (pl) 2020-06-15
MY185942A (en) 2021-06-14
GEP20207107B (en) 2020-05-11
ITUB20152860A1 (it) 2017-02-04
US10336687B2 (en) 2019-07-02
EP3331853B1 (en) 2019-12-11
AU2016302869A1 (en) 2018-03-15
BR112018002245A2 (pt) 2018-09-18

Similar Documents

Publication Publication Date Title
CA2767112C (en) Etomidate analogues that do not inhibit adrenocortical steroid synthesis
CN108026029B (zh) 经选择的γ-羟基丁酸的酰胺及其在治疗酒精误用中的用途
RU2659784C2 (ru) Сложноэфирное хиральное соединение (n-замещенный имидазол)-карбоновой кислоты, содержащее простую эфирную боковую цепь, его получение и применение
RS61506B1 (sr) Kompozicije fenfluramina i postupci za njihovu pripremu
FI78691C (fi) Foerfarande foer framstaellning av i position 3-substituerade pyridazinderivat, vilka inverkar pao det centrala nervsystemet.
JP5732400B2 (ja) 疼痛の治療で使用するための化合物
CN102112441B (zh) 吲哚衍生物作为nurr-1激活剂治疗帕金森病的用途
US9643971B2 (en) Breathing control modulating compounds, and methods of using same
RS55468B1 (sr) Jedinjenje benzotiazolona
JP5571072B2 (ja) アルファアドレナリン介在症状の治療方法
JP6610793B2 (ja) 環状アミン誘導体の結晶及びその医薬用途
WO2019112913A1 (en) Beta-2 selective adrenergic receptor agonists
EP2161998B1 (en) Pyridine derivatives as NET/SERT modulators
CN101855200A (zh) N-[4-(三氟甲基)苯甲基]-4-甲氧基丁酰胺的新型多晶型物
WO2010000019A1 (en) Pain-relieving compositions of furoxan no donors and uses thereof
BR112018002245B1 (pt) Composto amida selecionado do ácido ?-hidroxybutírico, processo para a preparação do referido composto, uso do referido composto e composição farmacêutica compreendendo o referido composto
KR20150047586A (ko) 베타-2-아드레날린수용체 효능제로서의 벤조티아졸론 화합물의 염
JPWO2013058361A1 (ja) アンドロゲン受容体拮抗化合物の結晶
HK1149249B (en) Polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide
HK1149249A (en) Polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20201204